Sharps Compliance — Investor Presentation (July 2007)
21 slides from Sharps Compliance's investor presentation, Jul 11, 2007
Slide 1: Sharps Compliance Investor Presentation July 2007
Sharps Compliance Defining Change Through Innovation Investor Presentation July 2007 SHARPS Copyright Sharps Compliance Corporation 2007 ‘Sharps Disposal By Mak™
Slide 2: Safe Harbor Statement
Safe Harbor Statement These slides contain (and the accompanying oral discussion will contain) “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. The words “believe”, “estimate”, “anticipate”, “project” and “expect” and similar expressions are in
Slide 3: Sharps Compliance Corp.
Sharps Compliance Corp. v OTC BB: SCOM.OB v Market capitalization* v 52-week range* v Recent price* Y Total shares outstanding Y Diluted shares outstanding v Avg. daily trading volume (3 mos.) v Insider ownership (excluding options) ¥ Fiscal Year-End * As of 7/09/07 a5 $38.4 million $3.99 - $0.80 $3
Slide 4: Sharps Delivers Solutions
Sharps Delivers Solutions > © aya j a FM Tracer® Sharps Disposal by Mail System® Internet-based tracking system Texas incineration facility Ea UNITED STATES POSTAL SERVICE «
Slide 5: Cost effective, Convenient, Efficient, Proven
v Cost effective v Convenient v Efficient v Proven
Slide 6: $1 Billion Market
$1 Billion Market Opportunity 9 to 10 2 billion used million syringes < 1% Market Penetration to Date Americans annually legally disposed of self-inject by SQG
Slide 7: Forces Driving Change
Forces Driving Change Government Regulations Non-Emergency Delivery California and Massachusetts Growing Retail Settings Growing Number of Injectable Drug Treatments Expanding Health Issues
Slide 8: Strategy for Growth
Strategy for Growth Our growth strategy is to aggressively pursue larger sales opportunities in key growth markets while leveraging our operating, service and administrative infrastructure to increase profitability and shareholder value.
Slide 9: Key Growth Markets
Key Growth Markets ' ‘4 ® 7 Pharmaceutical Manufacturers Commercial/ = Retail Industrial E = : = G4 Clinics/ s 4 Flu Shots Professional
Slide 10: Revenue mix by market, Q3 FY2007 TTM
Retail = 9.9% Commercial/ Industrial = 4.5% Hospitality = 6.9% Professional = 4.7% Others = 6.0% Pharmaceutical = 5.5% Agricultural = 4.7% Q3 FY2007 TTM Revenue = $11.8M Home Healthcare = 57.8%
Slide 11: Filling the Pipeline
Filling the Pipeline 6 Direct Sales: Strong Targeted ao. Regional and telesales Internet pisttibutor ; target market approach Marketing Pp: focused v Recent improvements: v New Senior V.P. with pharmaceutical and managed care background v Strengthened inside and telemarketing sales efforts
Slide 12: Solid Business Model
Solid Business Model Solid, Experienced Management Strong Margins First 15-40% Mover Quarterly Advantage Early Revenue Market Srowth Cie Penetration Revenue Business Model Building Blocks
Slide 13: Financial Highlights
Sharps Compliance Defining Change Through Innovation Financial Highlights SHARPS Copyright Sharps Compliance Corporation 2007 ‘Sharps Disposal By Mak™
Slide 14: Rapid Revenue Growth
Rapid Revenue Growth ($ in thousands) Customer Billings 2 Quarterly Trend $11,774 $10,563 $9,289 $8,419 $8,619 $9,001 $6,513 $7,830 9 SH PP SP OS ~~ se is PP PP POS AL eg fg f& SS KS © av < « < ee e
Slide 15: Realizing Operating Leverage
Realizing Operating Leverage Fiscal Year Operating Margin Operating Margin Quarterly Trend 9.9% 9.9% 4.3% S * Ss s ~ © r + : : : 1 é & . se se x os r os KS e e eg eS o< ¢ * Excludes $138,000 Q3 FY2007 special charge.
Slide 16: Bottom-line Profitability
Bottom-line Profitability ga) Vs ofim ($ in thousands) Fiscal Year Net Income Net Income Quarterly Trend $930 ¥ $382 $930 $118 $493 $329 J s s $1,278 e s M, 1 1 1 1 1 & & s Ss os ae Ss e e ay a Av gk « « < ee 7 e per share i * Excludes $138,000 Q3 FY2007 special charge.
Slide 17: Cash and EBITDA
(As of and for the period ending March 31, 2007) Cash and EBITDA cash (Third Quarter equivalents FYTD 2007)* * Computed as operating income for the nine months ended March 31, 2007 of $760,333 plus depreciation and amortization of $142,002 and a special charge of $138,000.
Slide 18: Strategy and Outlook
Sharps Compliance Defining Change Through Innovation Strategy and Outlook SHARPS Copyright Sharps Compliance Corporation 2007 ‘Sharps Disposal By Mak™
Slide 19: Government regulations driving change
Government regulations driving change Experienced management team Sales and marketing traction Market leader Lack of significant competition in SQG market Strong Board membership
Slide 20: Leader in the Small Quantity Generator market
Leader in the Small Recognized name brand Value-added products and services Consistent high-quality performance Powerful operating leverage Developing strong, nationwide customer base
Slide 21: Sharps Compliance
Sharps Compliance Defining Change Through Innovation Investor Presentation July 2007 SHARPS Copyright Sharps Compliance Corporation 2007 ‘Sharps Disposal By Mak™
Sharps Compliance — Investor Presentation (July 2007) on 6ix